Skip to Main Content

Paper Details

Class I Histone Deacetylase Inhibition for the Treatment of Sustained Atrial Fibrillation.
J Pharmacol Exp Ther
27
2016
4-(acetylamino)-N-(2-amino-phenyl) benzamide, AF, CI-994, Class I HDAC, Class I Histone Deacetylase, Dogs, HDAC, Hopx, N-acetyldinaline, Sustained Atrial Fibrillation, adipocyte, adipocytes, arrhythmia, atrial fibrosis, atrial immune cells, atrial tachypacing, chronic AF, class I HDAC, class I HDACs, dogs, histone deacetylase, immune cell, intra-atrial adipocytes, left, mice, mitral regurgitation, paroxysmal atrial fibrillation, patients
Author NameAffiliation
Steven R HouserCardiovascular Research Center (M.S., and Section of Clinical Cardiac Electrophysiology (J.S.A., Lewis Katz School of Medicine, Temple University, Pennsylvania Institute of Life Sciences, Italy (F.A.R.) and Children's Hospital of Philadelphia
Steven R HouserCardiovascular Research Center (M.S., and Section of Clinical Cardiac Electrophysiology (J.S.A., Lewis Katz School of Medicine, Temple University, Pennsylvania Institute of Life Sciences, Italy (F.A.R.) and Children's Hospital of Philadelphia
Vickas V PatelCardiovascular Research Center (M.S., and Section of Clinical Cardiac Electrophysiology (J.S.A., Lewis Katz School of Medicine, Temple University, Pennsylvania Institute of Life Sciences, Italy (F.A.R.) and Children's Hospital of Philadelphia
Fabio A RecchiaCardiovascular Research Center (M.S., and Section of Clinical Cardiac Electrophysiology (J.S.A., Lewis Katz School of Medicine, Temple University, Pennsylvania Institute of Life Sciences, Italy (F.A.R.) and Children's Hospital of Philadelphia
  • 1 - 4

Datasets

Release 1.2